BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dietz K, Raddatz G, Wallis J, Müller N, Zerr I, Duerr HP, Lefèvre H, Seifried E, Löwer J. Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis 2007;13:89-96. [PMID: 17370520 DOI: 10.3201/eid1301.060396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Vamvakas EC. Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented? Transfus Med Rev 2011;25:133-44. [PMID: 21345641 DOI: 10.1016/j.tmrv.2010.11.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
2 Garske T, Ghani AC. Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS One 2010;5:e15626. [PMID: 21203419 DOI: 10.1371/journal.pone.0015626] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
3 Beekes M. [Variant Creutzfeld-Jakob disease (vCJD) : Epidemiology and prevention from human to human secondary transmission]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010;53:597-605. [PMID: 20449549 DOI: 10.1007/s00103-010-1070-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Krasemann S, Neumann M, Geissen M, Bodemer W, Kaup FJ, Schulz-Schaeffer W, Morel N, Aguzzi A, Glatzel M. Preclinical deposition of pathological prion protein in muscle of experimentally infected primates. PLoS One 2010;5:e13906. [PMID: 21085647 DOI: 10.1371/journal.pone.0013906] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
5 Seitz R, Heiden M. Quality and Safety in Blood Supply in 2010. Transfus Med Hemother 2010;37:112-7. [PMID: 20577599 DOI: 10.1159/000314497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
6 Working Group ‘Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)’. Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated September 17, 2008. Transfus Med Hemother 2009;36:79-93. [PMID: 21048823 DOI: 10.1159/000188082] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Lefrère JJ, Hewitt P. From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France. Transfusion 2009;49:797-812. [PMID: 19170997 DOI: 10.1111/j.1537-2995.2008.02044.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
8 Gale P. The prion/lipid hypothesis - further evidence to support the molecular basis for transmissible spongiform encephalopathy risk assessment: PrP/lipid hypothesis. Journal of Applied Microbiology 2007;103:2033-45. [DOI: 10.1111/j.1365-2672.2007.03411.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Seitz R, von Auer F, Blümel J, Burger R, Buschmann A, Dietz K, Heiden M, Hitzler WE, Klamm H, Kreil T, Kretzschmar H, Nübling M, Offergeld R, Pauli G, Schottstedt V, Volkers P, Zerr I. Impact of vCJD on blood supply. Biologicals 2007;35:79-97. [DOI: 10.1016/j.biologicals.2007.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]